December 9th: COVID-19 VACCINES ARE COMING, NOW WHAT?
Register here: https://harvard.zoom.us/webinar/register/WN_6DDvCQqoSjeaYd0EGtxV3A Join the HMS-led Massachusetts Consortium on Pathogen Readiness (MassCPR) for a public briefing highlighting the latest developments on COVID-19 vaccine design, testing, approval, speed, safety and effectiveness, as well as key considerations for vaccine success. A panel discussion and question-and-answer session will follow. Speakers include: George Q….
Read MoreJoin the Massachusetts Consortium on Pathogen Readiness (MassCPR), including IMES faculty Bruce Walker, for a public briefing.
Algorithm reduces unnecessary use of antibiotics for UTIs
One paradox about antibiotics is that, broadly speaking, the more we use them, the less they continue to work. The Darwinian process of bacteria growing resistant to antibiotics means that, when the drugs don’t work, we can no longer treat infections, leading to groups like the World Health Organization warning…
Read MoreThree from MIT, including an IMES faculty member, receive National Institutes of Health Awards
Michael Birnbaum, Anders Hansen, and Tami Lieberman receive NIH Director’s New Innovator Awards from the NIH Common Fund’s High-Risk, High-Reward Research program. Three MIT faculty members have been chosen to receive the New Innovators Award from the National Institutes of Health (NIH) as part of its High-Risk, High-Reward Research program….
Read MoreA primer on viruses, vaccines, and therapies
New book for the general public by the founding director of IMES explains how novel viruses such as SARS-Cov-2 emerge and how we can fight them. Since the novel coronavirus SARS-Cov-2 emerged late last year, it has been virtually impossible to consume any news without encountering stories about the virus…
Read More